Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Gene Therapy to Target CD19 for Acute Lymphocytic Leukemia and Follicular lymphoma by Shenzhen BinDeBio for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Gene Therapy to Target CD19 for Acute Lymphocytic Leukemia and Follicular lymphoma is under clinical development by Shenzhen BinDeBio and...
Data Insights
Gene Therapy to Target CD19 for Acute Lymphocytic Leukemia and Follicular lymphoma by Shenzhen BinDeBio for Follicular Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Acute Lymphocytic Leukemia and Follicular lymphoma is under clinical development by Shenzhen BinDeBio and...